76 related articles for article (PubMed ID: 2334140)
1. In vivo model systems for assessing an anti-cancer drug: responses of autochthonous and transplanted prostate tumors to cyclophosphamide.
Pollard M; Luckert PH
Anticancer Res; 1990; 10(1):33-6. PubMed ID: 2334140
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
4. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.
Pollard M; Luckert PH
J Natl Cancer Inst; 1986 Aug; 77(2):583-7. PubMed ID: 3461217
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
[TBL] [Abstract][Full Text] [Related]
6. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
Rabbani SA; Harakidas P; Bowlin T; Attardo G
Cancer Res; 1998 Aug; 58(15):3461-5. PubMed ID: 9699681
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
[TBL] [Abstract][Full Text] [Related]
8. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
Naik H; Lehr J; Akhtar A; Pienta K
Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
[TBL] [Abstract][Full Text] [Related]
9. Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.
Raghow S; Kuliyev E; Steakley M; Greenberg N; Steiner MS
Cancer Res; 2000 Aug; 60(15):4093-7. PubMed ID: 10945615
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Lobund-Wistar x Copenhagen hybrid rats to autochthonous prostate carcinogenesis.
Suckow MA; Wolter W; Pollard M
Prostate; 2005 Jul; 64(2):203-8. PubMed ID: 15712219
[TBL] [Abstract][Full Text] [Related]
11. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
Jounaidi Y; Waxman DJ
Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
[TBL] [Abstract][Full Text] [Related]
12. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
Shiraga E; Barichello JM; Ishida T; Kiwada H
Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
[TBL] [Abstract][Full Text] [Related]
13. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.
Garikapaty VP; Ashok BT; Chen YG; Mittelman A; Iatropoulos M; Tiwari RK
Oncol Rep; 2005 Jan; 13(1):89-93. PubMed ID: 15583807
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
Drago JR; Goldman L; Gershwin ME
Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
[TBL] [Abstract][Full Text] [Related]
15. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
Wikström P; Lindahl C; Bergh A
Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
[TBL] [Abstract][Full Text] [Related]
17. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system.
Pollard M; Luckert PH
Prostate; 1987; 11(3):219-27. PubMed ID: 3684782
[TBL] [Abstract][Full Text] [Related]
18. Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.
Hodde JP; Suckow MA; Wolter WR; Hiles MC
J Surg Res; 2004 Aug; 120(2):189-94. PubMed ID: 15234212
[TBL] [Abstract][Full Text] [Related]
19. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
20. Can homeopathic treatment slow prostate cancer growth?
Jonas WB; Gaddipati JP; Rajeshkumar NV; Sharma A; Thangapazham RL; Warren J; Singh AK; Ives JA; Olsen C; Mog SR; Maheshwari RK
Integr Cancer Ther; 2006 Dec; 5(4):343-9. PubMed ID: 17101763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
